HOB Biotech Group (China), Hycor Biomedical (U.S.), Lincoln Diagnostics (U.S.), Omega Diagnostics (U.K.), Siemens Healthcare (Germany), Stallergenes (France), and Thermo Fisher Scientific (U.S)
(PRWEB) December 16, 2014
Increasing global incidence of allergic diseases, rising environmental pollution, and rapidly increasing global population of children aged 14 years and below (who are more susceptible to allergic diseases) are important growth drivers for the global market. The report provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the global allergy diagnostics market along with the estimates and forecasts of the revenue and market share analysis.
Browse 105 market data tables and 73 figures spread through 210 pages and in-depth Table of Content.
Early buyers will receive 10% customization on this report.
The global allergy diagnostics market is valued at $1,228.58 million in 2014. This market is expected to grow at a CAGR of 12.67% to reach $2,230.72 million in 2019.
The global allergy diagnostics market is segmented on the basis of allergen, end user, product, and geography. By allergen, the market is divided into food allergens, inhaled allergens, and other allergens. Of these, the inhaled allergens segment accounted for the largest share of the global allergy diagnostics market in 2014. The end-user segments included in this report are academic research institutes, diagnostics laboratories, hospitals, and other end users.
The instruments product segment is further sub segmented into immunoassay analyzers, luminometers, and other instruments. Of these, the immunoassay analyzers sub segment is expected to hold the largest share of the global allergy diagnostic instruments market in 2014, and is poised to grow at the highest CAGR between 2014 and 2019.
Get PDF Brochure @ http://www.marketsandmarkets.com/pdfdownload.asp?id=232871701
The geographic segments included in this report are Asia, Europe, North America, and the Rest of the World (RoW). The Asian segment is further divided into China, India, Japan, and the Rest of Asia. Europe is divided into France, Germany, Italy, Spain, the U.K., and the Rest of Europe. North America includes Canada and the U.S. The RoW encompasses Africa; Pacific and Oceania; and South America, Central America, and the Caribbean.
Rapidly increasing incidence of allergic diseases and rising environmental pollution will be important growth drivers for this market during the forecast period. Furthermore, the large proportion of children aged below 14 years, who are at a higher risk developing allergic disorders, will be an important driver for allergy diagnostics market.
Major players in the allergy diagnostics market include B BioMérieux (France), Danaher Corporation (U.S.), Hitachi Chemical Diagnostics (U.S.), HOB Biotech Group (China), Hycor Biomedical (U.S.), Lincoln Diagnostics (U.S.), Omega Diagnostics (U.K.), Siemens Healthcare (Germany), Stallergenes (France), and Thermo Fisher Scientific (U.S).
Browse Related Reports:
Point-Of-Care Diagnostics / Testing Market by Products (Glucose Monitoring & Infectious Diseases Testing Kits, Cardiac & Tumor Markers), by End Users (Self & Professional Monitoring), Over the Counter & Prescription Based - Global Forecast to 2018
Companion Diagnostics Market by Technology (Polymerase Chain Reaction, In-situ hybridization, Immunohistochemistry), Application (Breast, Lung cancer), & by End-user (Pharmaceutical Companies, Reference Lab)] - Global Trends & Forecasts to 2019
MarketsandMarkets is the world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 full time analysts and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, and identify sources of incremental revenues for both the company and its competitors.
M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas, TX 75252
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/medical-devices